🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The current study provides data necessary to evaluate the safety and immuno...
Status
Unknown
Location
Multiple Locations
Start Date
2022-01-25
Trial ID
NCT05140720
Treatments Being Tested
The proposed study is aimed at assessing the safety and immunogenicity of r...
Status
Completed
Location
Site 55 - Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
Start Date
2011-04
Trial ID
NCT01339923
The purpose of this study is to determine whether an early schedule of a co...
Status
Completed
Location
Menzies School of Health Research
Start Date
2011-08
Trial ID
NCT01174849
Treatments Being Tested
The primary objectives of this study are to evaluate the immunogenicity (an...
Status
Completed
Location
Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine (MRCG at LSHTM)
Start Date
2019-07-18
Trial ID
NCT03896477
Treatments Being Tested
The goal of this study is to evaluate the safety, tolerability, and immunog...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0015)
Start Date
2018-10-18
Trial ID
NCT03620162
Treatments Being Tested
Primary objective: This study aimed to demonstrate the non-inferiority of ...
Status
Completed
Location
Investigational Site Number : 2031006
Start Date
2018-12-14
Trial ID
NCT03547271
HYPOTHESES: 1. That infants receiving PHiD-CV10 as a booster at 12 months ...
Status
Completed
Location
Menzies School of Health Research
Start Date
2013-03-12
Trial ID
NCT01735084
Treatments Being Tested
This Phase III, open-label, randomized, parallel-group, active-controlled, ...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-07
Trial ID
NCT03205371
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of PATH-...
Status
Completed
Location
Kenya Medical Research Institute/Walter Reed Project
Start Date
2014-04
Trial ID
NCT02097472